Sort
15,842 grants matching “pancreatic cancer”
Tumor Hypoxia: Molecular Studies and Clinical Exploitation
$1,600,018Amato J. Giaccia · Stanford University · P01 · FY2013 · CA
UCLA SPORE in Prostate Cancer
$1,599,812Robert E Reiter · University Of California Los Angeles · P50 · FY2023 · CA
Multiscale Analysis of Immune Responses
$1,599,752Ronald Germain · National Institute Of Allergy And Infectious Diseases · ZIA · FY2019 · AI
Role of microbiome in cancer and inflammation
$1,596,434Giorgio Trinchieri · Division Of Basic Sciences - Nci · ZIA · FY2019 · CA
Comprehensive Management Strategy for GI Disorders
$1,595,777Cpm Systems, Inc. · R44 · FY2004 · DK
Pancreatic Cancer Metastasis
$1,594,959Surinder Kumar Batra · University Of Nebraska Medical Center · P01 · FY2019 · CA
Molecular Beacon Based Extracellular mRNA and Protein Detection for Early Cancer Diagnosis
$1,588,359Ly James Lee · Ohio State University · R33 · FY2017 · CA
Development and Preclinical Applications of Pancreatic Adenocarcinoma Models
$1,588,248Shyam Sharan · Division Of Basic Sciences - Nci · ZIA · FY2018 · CA
Tumor Hypoxia: Molecular Studies and Clinical Exploitation
$1,585,768Amato J. Giaccia · Stanford University · P01 · FY2017 · CA
Tumor Hypoxia: Molecular Studies and Clinical Exploitation
$1,585,768Amato J. Giaccia · Stanford University · P01 · FY2016 · CA
Tumor Hypoxia: Molecular Studies and Clinical Exploitation
$1,585,768Amato J. Giaccia · Stanford University · P01 · FY2015 · CA
Role of C-EBP transcription factors in cell growth and tumorigenesis
$1,583,541Peter F Johnson · Division Of Basic Sciences - Nci · ZIA · FY2019 · CA
Chronic Pancreatitis Clinical Research Consortium (CPCRC) Data Coordinating Center (CPCRC-DCC)
$1,583,252Liang Li · University Of Tx Md Anderson Can Ctr · U01 · FY2025 · DK
Consortium for the Study of Chronic Pancreatitis, Diabetes and Pancreatic Cancer: Coordinating and Data Management Center (CSCPDPC-CDMC)
$1,582,014Ziding Feng · University Of Tx Md Anderson Can Ctr · U01 · FY2015 · DK
Tumor Hypoxia: Molecular Studies & Clinical Exploitation
$1,581,538Amato J. Giaccia · Stanford University · P01 · FY2007 · CA
NEW STRATEGIES TO TARGET PANCREATIC CANCER
$1,578,333University Of California, San Diego · · FY2020 · Department of the Army
Proteases in Cancer Biology and Drug Development
$1,572,052Zena Werb · University Of California, San Francisco · P01 · FY2006 · CA
Proteases in Cancer Biology and Drug Development
$1,569,832Zena Werb · University Of California, San Francisco · P01 · FY2007 · CA
Proteases in Cancer Biology and Drug Development
$1,565,484University Of California San Francisco · P01 · FY2005 · CA
Mechanisms of non-classical multidrug resistance in cancer
$1,563,961Michael Gottesman · Division Of Basic Sciences - Nci · ZIA · FY2024 · CA
Clinical Studies of the Molecular Genetic Basis of Kidney Cancer
$1,563,629William Marston Linehan · Division Of Basic Sciences - Nci · ZIA · FY2024 · CA
Validation of biomarkers for early diagnosis and risk prediction of pancreatic neoplasms
$1,563,388Randall Brand · University Of Pittsburgh At Pittsburgh · U01 · FY2018 · CA
Alpha-Tocopherol, Beta-Carotene Cancer Prevention (ATBC) Study
$1,563,189Demetrius Albanes · Division Of Cancer Epidemiology And Genetics · ZIA · FY2010 · CA
ImaginAb
$1,560,423Green Zhang · Imaginab, Inc. · N44 · FY2014 · CA
Functional Annotation of the Pancreatic Cancer Genome
$1,559,319Steven D Leach · Johns Hopkins University · P01 · FY2010 · CA